Patents by Inventor Thomas DUCH

Thomas DUCH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liquid pharmaceutical compositions comprising SGLT-2 inhibitors
    Patent number: 10709683
    Abstract: The invention relates to novel liquid pharmaceutical compositions comprising at least one SGLT-2 inhibitor and one or more polar organic solvents, wherein the at least one SGLT-2 inhibitor comprises 1-cyano-2-(4-cyclopropyl-benzyl)-4-(?-D-glucopyranos-1-yl)-benzene according to formula (I): as well as corresponding processes of manufacturing such liquid pharmaceutical compositions and their medical uses.
    Type: Grant
    Filed: January 2, 2019
    Date of Patent: July 14, 2020
    Inventors: Claudius Weiler, Thomas Duch, Marbod Haase, Timothy Shane Priddy, Heike Stettler
  • Liquid Pharmaceutical Compositions Comprising SGLT-2 Inhibitors
    Publication number: 20190142787
    Abstract: The invention relates to novel liquid pharmaceutical compositions comprising at least one SGLT-2 inhibitor and one or more polar organic solvents, wherein the at least one SGLT-2 inhibitor comprises 1-cyano-2-(4-cyclopropyl-benzyl)-4-(?-D-glucopyranos-1-yl)-benzene according to formula (I): as well as corresponding processes of manufacturing such liquid pharmaceutical compositions and their medical uses.
    Type: Application
    Filed: January 2, 2019
    Publication date: May 16, 2019
    Inventors: Claudius Weiler, Thomas Duch, Marbod Haase, Timothy Shane Priddy, Heike Stettler
  • Liquid pharmaceutical compositions comprising SGLT-2 inhibitors
    Patent number: 10220017
    Abstract: The invention relates to novel liquid pharmaceutical compositions comprising at least one SGLT-2 inhibitor and one or more polar organic solvents, wherein the at least one SGLT-2 inhibitor comprises 1-cyano-2-(4-cyclopropyl-benzyl)-4-(?-D-glucopyranos-1-yl)-benzene according to formula (I): as well as corresponding processes of manufacturing such liquid pharmaceutical compositions and their medical uses.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: March 5, 2019
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Claudius Weiler, Thomas Duch, Marbod Haase, Timothy Shane Priddy, Heike Stettler
  • LIQUID PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS
    Publication number: 20170056366
    Abstract: The invention relates to novel liquid pharmaceutical compositions comprising at least one SGLT-2 inhibitor and one or more polar organic solvents, wherein the at least one SGLT-2 inhibitor comprises 1-cyano-2-(4-cyclopropyl-benzyl)-4-(?-D-glucopyranos-1-yl)-benzene according to formula (I): as well as corresponding processes of manufacturing such liquid pharmaceutical compositions and their medical uses.
    Type: Application
    Filed: August 24, 2016
    Publication date: March 2, 2017
    Inventors: Claudius WEILER, Thomas DUCH, Marbod HAASE, Timothy Shane PRIDDY, Heike STETTLER